VA
MED icon

Verdad Advisers’s Medifast MED Stock Holding History

Verdad Advisers’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$109K Sell
10,234
-2,914
-22% -$33.6K 0.1% 185
2026
Q1 		$134K Buy
+13,148
New +$142K 0.15% 145

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Verdad Advisers's MED Position: Q2 2026 in Review

Verdad Advisers reduced its Medifast (MED) stake by 22% in Q2 2026, selling an estimated $33.6K and leaving 10,234 shares worth $109K. The position accounts for 0.1% of the portfolio, ranked #185.

Verdad Advisers first reported a position in MED in Q1 2026 and has held it in 2 quarters since. The position peaked at $134K in Q1 2026. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Verdad Advisers held 10,234 shares of Medifast worth $109K as of Q2 2026.
  • Verdad Advisers sold 2,914 Medifast shares in Q2 2026, an estimated $33.6K.
  • Medifast made up 0.1% of Verdad Advisers's portfolio in Q2 2026, its #185 holding.
  • Verdad Advisers first reported a position in Medifast in Q1 2026 and has held it in 2 quarters since.
  • Verdad Advisers's Medifast position peaked at $134K in Q1 2026.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Verdad Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.